Abstract: Transgenic mice hemizygously carrying human c-Ha-ras proto-oncogene, TgrasH2 show very sensitive and facilitated carcinogenicity to various carcinogens. In this study, activities of certain enzymes related to drug metabolism and energy metabolism were measured in microsome and cytosol fractions of livers of Tg-rasH2 mice and their wild type littermates with both sexes treated with 3-methylcholanthrene (MC) and phenobarbital (PB). Aminopyrine N-demethylase activities increased significantly in livers of all mice treated with PB. MC and PB treatments induced significant increases in activities of UDP-glucuronosyltransferase and S-adenosyl homocysteinase compared to those in the non-treated groups in microsome fractions from all mice. In cytosol fractions of livers of all mice, glutathione S-transferase activity was significantly induced in the PB treated groups. There were no significant differences in activities of lactate dehydrogenase, glucose 6-phosphate dehydrogenase, pyruvate kinase and glucose 6-phosphatase related to energy metabolism in livers and kidneys among all mice. TgrasH2 mice showed stable activities of enzymes related to drug detoxication and energy metabolism similar to those of non-transgenic mice. These results suggest that the human c-Ha-ras transgene may not affect drug metabolism-related enzymes, and the facilitated carcinogenic response in the Tg-rasH2 mouse is not due to these enzymatic disorders.
Introduction
Carcinogenicity tests are indispensable in the evaluation of the safety of new drugs in the process of development and also in the identification of environmental carcinogens. The current carcinogenicity test using conventional rodents requires more than 2 years, a large number of animals and high costs. Therefore, the development of alternative testing systems that can evaluate carcinogenicity within a shorter period is essential for improving the efficiency of the development of new drugs and the identification of environmental carcinogens. Transgenic animals harboring an oncogene and/or animals lacking a tumor suppressor gene are expected to be more susceptible to various carcinogens than normal animals [18] . Tg-rasH2 mice hemizygously carrying the prototype human c-Ha-ras gene, which were established by Saitoh et al. [23] , show high and rapid susceptibility to various carcinogens and are considered to be promising as an animal model for an alternative rapid carcinogenicity test [19, 26] . In addition, the phenotypes of high and rapid carcinogenesis in transgenic mice may be useful for evaluating new anticancer drugs or cancer prevention.
It has been reported that 3-methylchoranthrene (MC), a carcinogenic aromatic compound and phenobarbital (PB), a typical sedative increase activities of certain drug metabolizing enzymes [16, 28] . It has also been reported that the activities of certain enzymes in glycolysis or the pentose phosphate pathway are significantly increased in most tumor cells [1, 6] .
To use Tg-rasH2 mice as an animal model for alternative rapid carcinogenicity testing as well as for other purposes, it is necessary to investigate the changes in activities of drug metabolizing enzymes in the animal tissues since various substances with carcinogenic potential are activated or inactivated by the enzymes. Because non-transgenic littermates are also utilized as controls for the alternative carcinogenicity test, it is also necessary to confirm whether the changes in activities of drug metabolizing enzymes in Tg-rasH2 mice are similar to those in non-transgenic littermates. In the present study, we measured the activities of certain enzymes related to drug detoxication in microsome and cytosol fractions of the livers and kidneys of Tg-rasH2 mice and their wild type littermates treated with MC and PB as well as some energy metabolism-related enzymes.
Materials and Methods

Animals and treatment:
Transgenic mice carrying the prototype human c-Haras gene, Tg-rasH2 mice, were originally established by Saitoh et al. [23] . In the present study, F1 of a transgenic male C57BL/6J and normal female BALB/ cByJ were used. The F1 offspring were screened by the polymerase chain reaction, and divided into transgenic (-/Tg) and non-transgenic mice (-/-). Mice were housed in an air-conditioned room (23 ± 2°C, 55 ± 10%) with a light period of 12 hr. Food and water were available ad libitum. All procedures involving laboratory animals were performed in accordance with the care and use guidelines of the Central Institute for Experimental Animals (Kawasaki, Japan). Male and female transgenic and non-transgenic mice, were divided into 4 groups consisting of 10 mice each. One group (MC treated) was administered intraperitoneally 3-methylcholanthrene (SIGMA, MO, USA) dissolved in sesame oil (Wako Pure Chemical Inc., Tokyo, Japan) at a dose of 25 mg/kg body weight every day for 2 consecutive days. The second group (PB treated) was administered intraperitoneally sodium phenobarbital (Wako Pure Chemical Inc.) in saline at a dose of 50 mg/kg for 3 consecutive days. The third and the fourth groups were given sesame oil for 2 consecutive days, or saline for 3 consecutive days, respectively, intraperitoneally at 0.1 ml/10 g of body weight as vehicle treated controls. The saline treated group was regarded as the unmedicated control in the present study. At 24 hr post treatment, all mice were sacrificed by decapitation and their livers and kidneys were removed immediately, frozen in liquid nitrogen, and stored at -80°C until use.
Preparation of microsome and cytosol fractions of tissues:
Frozen tissues were thawed quickly and homogenized with 4 volumes of cold 1.15% KCl solution containing 1 mM EDTA in a Potter Elvehjem type homogenizer (Takashima, Tokyo, Japan). The homogenate was centrifuged at 9,000 g for 20 min at 4°C, and the supernatant was then centrifuged at 100,000 g for 60 min at 4°C. The resulting microsome pellet was suspended in 0.1 M phosphate buffer (pH 7.5), and the supernatant was saved as the cytosol fraction. Both microsome and cytosol fractions were stored at -80°C until use.
Assay of enzyme activities:
Activities of aminopyrine N-demethylase and aniline hydroxylase as phase I detoxifying enzymes, and UDPglucuronosyltransferase (UDP-GT), glutathione S-transferase (GST) and S-adenosyl homocysteinase as phase II detoxifying enzymes were measured. We also measured some energy metabolism-related enzymes such as glucose-6-phosphatase (G6Pase), lactate dehydrogenase (LDH), glucose-6-phosphate dehydrogenase (G6PD), and pyruvate kinase (PK) as control marker enzymes between transgenic and wild type littermates. They were measured by previously reported methods: G6Pase [3] , aniline hydroxylase [12] , aminopyrine Ndemethylase [20] , UDP-GT [7] , and S-adenosyl homocysteinase [8] in microsome fractions and GST [2] , LDH [15] , G6PD [4] , and PK [11] in cytosol fractions. All enzymatic activities were determined at 24 to 26°C and expressed as nmol of substrate degraded per minute per mg of protein. Protein concentrations were determined by the method of Bradford [5] using bovine serum albumin as the standard.
Statistics:
All enzymatic activities were expressed as means ± SD. The data were analyzed statistically using Student's t-test; p<0.01 was considered statistically significant. Table 1 shows enzyme activities in microsome fractions of livers from all mice. There were no significant differences in activities of G6Pase, a marker enzyme of microsomes, and aniline hydroxylase among all treatment groups for all mice. Aminopyrine N-demethylase activities increased significantly in the PB treated group compared to those in the non-treated group for all mice. MC and PB treatments induced significant increases in activities of UDP-GT and S-adenosyl homocysteinase compared to those in the non-treated group for all mice. Enzyme activities in cytosol fractions of the livers are shown in Table 2 . No significant differences in activities were observed in LDH as a marker enzyme of cytosol, G6PD in the pentose phosphate pathway and PK in glycolysis among treatment groups of all mice. In cytosol fractions of the livers of all mice, only GST 241 ± 38 0.8 ± 0.3 3.6 ± 0.5 22 ± 6* 31 ± 3* PB 277 ± 37 1.0 ± 0.1 9.0 ± 1.0* 23 ± 6* 29 ± 7* sesame oil 224 ± 29 1.0 ± 0.6 3.6 ± 0.9 12 ± 3 21 ± 4 saline 244 ± 16 0.9 ± 0.1 3.8 ± 0.7 9 ± 3 16 ± 4
Results
Activities (nmol/min/mg protein) are given as means ± SD of 10 mice in each group. * Significantly higher (p<0.01) than the values of saline group in the same kind of mice.
activities in the PB treated group were significantly elevated compared to those in the control group. Tables  3 and 4 show enzyme activities in the microsome and cytosol fractions of kidneys from all mice. There were no significant differences in G6Pase and UDP-GT activities among groups for all mice. Aniline hydroxyalse, aminopyrine N-demethylase and S-adenosyl homocysteinase activities were not detected with the present assay systems in microsome fractions of kidneys from any of the mice. Significant differences were not observed in these enzyme activities between any group of mice. Finally, we statistically compared all data from transgenic and wild type non-transgenic mice, and no significant differences were shown in activated as well as constitutive enzymatic activities.
Discussion
For the application of transgenic and knockout animals to the alternative rapid carcinogenicity test, analysis of enzyme induction among strains including wild types is an important factor in the validation of results of carcinogenic response, especially at the high maximum tolerated dose of the tested substance [10] , since, in practice, preliminary dose finding studies for the carcinogenecity test are usually performed using wild type littermates. Treatment with MC and PB is known to induce an increase in activities of some of enzymes including cytochrome P450s in animal tissues [13, 28] . In the present study, treatment with PB induced an increase in the activity of aminopyrine N-demethylase, one of the phase I detoxifying enzymes as cytochrome P450, in livers of both Tg-rasH2 and non-transgenic mice. Moreover, treatment with MC and PB activated UDP-GT and S-adenosyl homocysteinase that have very important roles in drug detoxication systems in the livers of mice as well as in other animal species [22, 29] . No significant differences were observed when these activated, as well as constitutive, enzyme activities were compared between transgenic and wild type non-transgenic mice. Treatment with MC and PB had no influence on the activities of LDH, G6PD, PK and G6Pase, which are related to Activities (nmol/min/mg protein) are given as means ± SD of 10 mice in each group. * Significantly higher (p<0.01) than the values of saline group in the same kind of mice. Gollapudi et al. reported differences in both constitutive and induced drug metabolizing enzyme activities between some genetically-engineered mice such as p53 knockout mice and their wild type counterparts [10] , suggesting some degree of strain divergence between the transgenic and the parental strain. Although the mechanisms of the divergence observed in p53 knockout mice remain unclear, one possible reason for it may be an immature congenic process in the breeding of the strain. In the present study, we used F1 of transgenic male C57BL/6J and normal female BALB/cByJ, and backcrossing of the Tg-rasH2 mice to C57BL/6J was up to N14. Recently, a mouse lacking nrf2 gene was developed by Itoh et al., and it was reported that induction of phase II detoxifying enzymes was largely eliminated in this mouse due to dysfunction of activation pathways through antioxidant response elements [14] .
It was reported that tumor cells showed higher uptake of glucose and other compounds than normal cells [17, 24] , and changes in the characteristics of transformed cells with proto-oncogenes are frequently observed [9, 25] . G6PD in the pentose phosphate pathway are elevated significantly and used as prognostic indicators of mammary tumors [21] . In the present study, 7 to 8 weeks old Tg-rasH2 mice were used. In these mice, neoplasms were not observed macroscopically in any tissue at autopsy. After 20 weeks of age, tumors of some kind are observed in Tg-rasH2 mice [27] . In Tg-rasH2 mice which had no neoplasms at 7 to 8 weeks of age, these enzyme activities were stable within normal ranges.
In conclusion, Tg-rasH2 mice are characterized by very stable activities of enzymes related to drug detoxication and energy metabolism in their livers and kidneys compared to those in the non-transgenic control. TgrasH2 mice are considered to be a promising alternative model animal for the evaluation of new drugs as well as for the alternative rapid carcinogenicity test.
